Gyre Therapeutics (GYRE) Return on Assets [ROA] (2011 - 2026)
Gyre Therapeutics' Return on Assets [ROA] was -10.83% in Q2 2026, down 14.31 percentage points from 3.49% a year earlier and down 6.89 percentage points from the prior quarter.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Return on Assets [ROA] (2011 - 2026) Analysis & Trends
For FY2025, Return on Assets [ROA] at Gyre Therapeutics came in at 5.72%, down 9.07 percentage points from FY2024.
- Return on Assets [ROA] shows a five-year change of +63.89 percentage points (FY2020 to FY2025).
- In earlier years, Return on Assets [ROA] was 14.80% in FY2024 (+99.73 pp), -84.93% in FY2023 (-91.08 pp), 6.14% in FY2022 (+122.99 pp) and -116.85% in FY2021 (-58.69 pp).
- The Q2 2026 figure marks the lowest quarterly Return on Assets [ROA] since Q3 2024.
- Compared with a year earlier, Return on Assets [ROA] has declined for three straight quarters, with an average year-over-year change of +46.44 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Assets [ROA] over five years was Q1 2023 (a gain of 211.42 percentage points); the worst was Q2 2023 (a drop of 145.53 percentage points).
- Per Business Quant data, GYRE's Return on Assets [ROA] in the three quarters before Q2 2026 was -3.94% (Q1 2026), 3.20% (Q4 2025) and 5.13% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.14% |
| 10 | Gyre Therapeutics | 753.90 Mn | 556.61 Mn | 26.90 Mn | -10.83% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10.83% |
| Mar 31, 2026 | -3.94% |
| Dec 31, 2025 | 3.20% |
| Sep 30, 2025 | 5.13% |
| Jun 30, 2025 | 3.49% |
| Mar 31, 2025 | 9.17% |
| Dec 31, 2024 | 14.28% |
| Sep 30, 2024 | -67.96% |
| Jun 30, 2024 | -65.03% |
| Mar 31, 2024 | -66.87% |
| Dec 31, 2023 | -135.14% |
| Sep 30, 2023 | -110.93% |
| Jun 30, 2023 | -159.23% |
| Mar 31, 2023 | 44.57% |
| Dec 31, 2022 | 7.45% |
| Sep 30, 2022 | 20.78% |
| Jun 30, 2022 | -13.70% |
| Mar 31, 2022 | -166.84% |
| Dec 31, 2021 | -131.05% |
| Sep 30, 2021 | -95.95% |
API Access
Gyre Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();